Extended-release dosage form

Details for Australian Patent Application No. 2008211318 (hide)

Owner Mylan Pharmaceuticals, Inc.

Inventors Shaw, Andrew A.; Chattaraj, Sarat C.; Bhat, Pavan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008211318

PCT Pub. Number WO2008/094440

Priority 11/701,178 01.02.07 US

Filing date 24 January 2008

Wipo publication date 7 August 2008

International Classifications

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/094440 Priority application(s): WO2008/094440

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008211358-Induction of Xa27 by the avrXa27 gene in rice confers broad-spectrum resistance to xanthomonas oryzae pv. oryzae and enhanced resistance to xanthomonas oryzae pv. oryzicola

2008211306-Ophthalmic lens mold having vent portion around a circumference